Related references
Note: Only part of the references are listed.Managing hepatitis B/HIV co-infected: adding entecavir to truvada (tenofovir disoproxil/emtricitabine) experienced patients
Libuse Ratcliffe et al.
AIDS (2011)
The rtA194T Polymerase Mutation Impacts Viral Replication and Susceptibility to Tenofovir in Hepatitis B e Antigen-Positive and Hepatitis B e Antigen-Negative Hepatitis B Virus Strains
Samad Amini-Bavil-Olyaee et al.
HEPATOLOGY (2009)
Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations
J. Audsley et al.
HIV MEDICINE (2009)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
Patrick Marcellin et al.
JOURNAL OF HEPATOLOGY (2009)
Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure
Stephen Locarnini
HEPATOLOGY INTERNATIONAL (2008)
Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure
Stephanie Villet et al.
JOURNAL OF HEPATOLOGY (2008)
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Patrick Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Antiviral drug-resistant HBV: Standardization of nomenclature and assays and recommendations for management
Anna S. Lok et al.
HEPATOLOGY (2007)
Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus
WE Delaney et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
HBV drug resistance: Mechanisms, detection and interpretation
T Shaw et al.
JOURNAL OF HEPATOLOGY (2006)
Share Paper
